|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 104, 173-178, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
DE Low and KM Pagliero
Twenty-three consecutive patients with advanced esophageal cancer were
randomized to receive either endoluminal irradiation or laser photoablation
treatment. Initial improvement in dysphagia scores was observed in 83%
(brachytherapy) and 91% (laser). This improvement in dysphagia was
maintained at 2 months in 75% (brachytherapy) and 81% (laser). Performance
scores improved in 33% (brachytherapy) and 36% (laser). Both treatments
were well tolerated, required a minimum of inpatient treatment time, and
allowed patients to die without terminal admission to district referral
centers. Retreatments were three times as common with laser therapy, but
the frequency of treatment failures was equal. Minor complications,
especially transient early dysphagia, was more common in the brachytherapy
group, although the only major complication (perforation) occurred in the
laser group. No procedure- related deaths occurred in either group.
ARTICLES
Prospective randomized clinical trial comparing brachytherapy and laser photoablation for palliation of esophageal cancer
Department of Thoracic Surgery, Royal Devon and Exeter Hospital, England.
This article has been cited by other articles:
![]() |
V. R. Litle, J. D. Luketich, N. A. Christie, P. O. Buenaventura, M. Alvelo-Rivera, J. S. McCaughan, N. T. Nguyen, and H. C. Fernando Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients Ann. Thorac. Surg., November 1, 2003; 76(5): 1687 - 1693. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |